Lancet Oncol 8: 21–25 Finasteride, a type 2 5α-reductase inhibitor, is used to treat benign prostatic hyperplasia (BPH) at 5 mg daily, and male-pattern alopecia at 1 mg daily. The 5 mg regimen ...

Finasteride, also known by brand names ... which suggests around 350,000 a month were taking the daily 5mg pill for an enlarged prostate. It is not known how many people get the drug for hair ...

Debruyne et al. [69] conducted a multicenter, randomized study of 1051 patients with BPH. Patients received ER alfuzosin 5 mg twice daily, finasteride 5 mg daily, or both drugs for six months.

The recent completion of PCPT using the drug finasteride has provided the first evidence that a chemopreventive agent can reduce the risk of developing prostate cancer High-grade cancers were ...

Finasteride, which is used in the treatment of benign prostatic hyperplasia (BPH), has been associated with a range of sexual adverse effects. The reported incidences of such effects have been ...